European Commission Awards Orphan Designation to Knopp NeuroSciences’ KNS-760704 in ALS

March 10, 2009 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

PITTSBURGH--(BUSINESS WIRE)--Knopp Neurosciences Inc. (“Knopp”) today announced that the European Commission (“EC”) has designated KNS-760704 as an orphan medicinal product for the treatment of Amyotrophic Lateral Sclerosis.

Twitter
LinkedIn
Facebook
Email
Print

Clinical research Phase 2